title: [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medical treatment for osteoporosis].
abstract: The main revisions to the item of medical treatment in the 2015 edition of the Guidelines for Prevention and Treatment of Osteoporosis are the additions of the drugs such as ibandronate, teriparatide acetate (once-weekly preparation), and denosumab, which were approved after the release of the 2011 edition, and of information on new dosage forms for existing drugs. Furthermore, the heading "Evaluation and Recommendations" for each drug was changed to "Evaluation of Efficacy" . The choice of drug is determined based on evidence for the effectiveness of each drug and in accordance with the age, fracture risk, and pathophysiology of each patient. As for the selection and combined use of the various drugs, accumulation of evidence is anticipated, but sequential therapy using antiresorptive agents following treatment with teriparatide preparations is recommended.
authors: Internal Medicine 1, Shimane University Faculty of Medicine, Japan.
authors: Mika
authors: M
authors: Yamauchi
authors: Toshitsugu
authors: T
authors: Sugimoto
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D017410:Practice Guidelines as Topic
chemical_list: D050071:Bone Density Conservation Agents; D004338:Drug Combinations